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Abstract: Nordic Nutrition Recommendations (NNR) recommend exclusive breastfeeding until
6 months, partial breastfeeding until 1 year or longer and irrespective of breastfeeding, avoiding solid
foods before 4 months. Strong evidence was found for benefits of breastfeeding regarding growth
and infections but limited/inconclusive evidence regarding atopic disease and asthma. Vitamin D is
of special interest in the Nordic diet. The aim of this prospective study was to compare infant feeding
and vitamin D between immunoglobulin E (IgE) sensitized (n = 14) and non-sensitized (n = 130)
children at 6 years. Information on diet and vitamin D supplement use were collected with dietary
recall (<5 months), 1-d food records (5 and 6 months) and 3-d weighed food records (12 months and
6 years). Serum-specific IgE-antibodies against milk, egg, cod, wheat, soy and peanut (cut-off specific
IgE ≥ 0.35 kUA/L) were measured at 6 years and serum 25-hydroxyvitamin D at 12 months and
6 years. At 4 months, 57% of IgE sensitized vs. 23% of non-sensitized children (p < 0.01) had received
solid food. At 12 months, IgE sensitized children had a lower intake of vitamin D (median (25th, 75th
percentiles): 3.9 µg/d (3.2, 7.2) vs. 8.1 µg/d (4.4, 12.3), p = 0.03) and at 6 years, fewer used vitamin D
supplements regularly (23% vs. 56%, p = 0.03). Introduction of solid foods prior to 4 months increased
the odds of IgE-sensitization, OR = 4.9 (95%, CI = 1.4–16.6) and vitamin D supplement at 6 years
decreased the odds of IgE-sensitization, OR = 0.2 (95%, CI = 0.1–0.98), adjusting for maternal smoking.
These observations support the NNR in their recommendation against introducing complementary
solid foods before the age of 4 months. Furthermore, they support encouraging vitamin D intake for
young children at northern latitudes.
Keywords: Nordic diet; infants; children; recommendations; IgE sensitization; breastfeeding;
complementary feeding; solid food; vitamin D
1. Introduction
Dietary approaches to preventing food allergies are currently the topic of much research and may
have implications for infant nutrition recommendations [1,2]. The Nordic Nutrition Recommendations
(NNR) recommend exclusive breastfeeding until the infant is about 6 months old [3]. The frequency of
breastfeeding is high in the Nordic countries: Data from 2006–2012 show that about 95% of newborns
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are breastfed and 68%–85% still receive any amount of breastmilk at the age of four months [4].
The most recent data from Denmark, Norway and Sweden, show similar values for breastfeeding [5–7].
Most Nordic infants, however, receive complementary foods before the age of 6 months in Denmark,
Finland, Iceland, Norway and Sweden. At the age of 4 months, 23%–63% are exclusively breastfed,
falling to 0%–12% at the age of 6 months [4]. The Nordic Nutrition Recommendations on breastfeeding
state that some infants will need complementary feeding before 6 months of age, but they emphasize
that solid food should not be introduced before the age of 4 months [3]. While most official bodies
recommend exclusive breastfeeding for either the first 6 months or at least 4–6 months for health-related
endpoints [3,8–10], there is a debate regarding the optimal age of introduction of solid food as primary
prevention to reduce atopy and allergy [1]. The systematic literature review on breastfeeding prepared
for the Nordic Nutrition Recommendations gave the lowest grade of evidence for any preventive
effects of breastfeeding on the risk of atopic diseases in children, so no conclusions were drawn, while
for most other undesirable outcomes there was convincing or probable evidence for the protective
effects of breastfeeding [4]. Similarly, recent systematic literature reviews found the data inconclusive
regarding the effect of breastfeeding on the risk of atopic diseases [11,12].
Due to the northern latitude, vitamin D is of special importance in the Nordic countries. In the
NNR as well as national guidelines in all Nordic countries, parents are advised to give vitamin D
supplements (10 µg/d) to their infants [3]. The importance of vitamin D supplement intake for vitamin
D status at 12 months and 6 years of age in an Icelandic longitudinal cohort has been reported [13,14].
While vitamin D deficiency in infancy or childhood has been associated with higher immunoglobulin
E (IgE) levels and sensitization to food allergens [15,16], other studies suggest that infant vitamin D
supplementation increases the risk of later atopy and allergy [17–19].
The detection of serum-specific IgE to common food allergens indicates a state of sensitization,
although in isolation it does not prove the existence of clinical allergy [20]. Studies have suggested that
about half of sensitized children have a food allergy, clinically proven by food challenge [21]. However,
according to a model by Grimshaw et al., primary prevention of allergies should focus on preventing
immunological sensitization [2]. Therefore, we decided to test for serum-specific IgE to common food
allergens at 6 years in the Icelandic longitudinal cohort with detailed information of the timing of solid
food introduction and repeated information on the use of vitamin D supplements throughout the first
year of life and in a follow-up at 6 years. Our aim was to compare feeding in infancy and vitamin D
intake between sensitized and non-sensitized children.
2. Materials and Methods
2.1. Participants and Design
Previous publications have described in detail the study population (a random sample of
250 Icelandic infants born in 2005), recruitment and data collection throughout the first year of life and
at follow-up at 6 years [22,23]. The inclusion criteria were Icelandic (Caucasian) parents, singleton birth,
37–41 weeks gestational length, birth weight within 10th–90th percentiles, absence of birth defects or
congenital long-term diseases and regular antenatal care of the mother. The current study includes
144 children who participated in blood sampling in the follow-up at 6 years and had allergen-specific IgE
levels analyzed (84% of the children in the follow-up). As previously described, children participating
in the blood sampling did not differ from the original sample in birth size and breastfeeding [24] and the
basic characteristics of subjects included in this study did not differ from other subjects in the follow-up.
Informed written consent from the parents was obtained for the study and all participant information
was processed with strict confidentiality. The study was conducted according to the Declaration of
Helsinki, approved by the National Bioethics Committee (VSNb2005040019/037; VSNb2011010008/037)
and registered at the Data Protection Authority (S2449/2005; S5099/2011) in Iceland.
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2.2. Dietary Assessments
Detailed information about infant feeding from birth until 4 months (17 weeks) including
breastfeeding, the introduction of infant formula and solid food and use of vitamin D or other dietary
supplements were gathered with one structured dietary recall facilitated by a trained interviewer
(mean infant age at dietary recall 21 weeks). The exact age when the first infant formula and first solid
food was introduced to the diet, along with the type of formula or solid was registered. At 5 and
6 months, non-weighed intake was registered for 1 day (24 h) and at 12 months and 6 years weighed
food records were kept for 3 consecutive days (72 h), thereof two weekdays and one weekend day
(either Sunday–Tuesday or Thursday–Saturday). All food and fluids were weighed on accurate scales
(Philips type HR 2385, Hungary and Austria) with 1 g precision. Dietary supplements and medicines
were also registered. An average daily consumption of food and nutrients was calculated using the
Icelandic food composition database [25] which included infant products, such as porridges, purées
and cereals. Total vitamin D intake included vitamin D from food and supplements. Vitamin D
supplement doses were most often between 6 and 10 µg/d. Since the doses did not differ greatly in
amount, participants were classified as using vitamin D supplements if they received any amount of
cod liver oil or another type of vitamin D containing supplement.
2.3. Blood Sampling and Biochemical Analysis
At 12 months and 6 years, venous blood samples were collected in the morning in a fasting state
at Landspitali University Hospital by a certified pediatrician and centrifuged within 6 h of collection.
Separated serum samples were stored at −80 ◦C at the biobank at Landspitali until analyses were
carried out by biomedical scientists at Landspitali for serum 25(OH)D at 12 months (April 2013), serum
25(OH)D at 6 years (December 2013) and serum-specific IgE to food allergens at 6 years (January 2014).
Serum 25(OH)D levels were analyzed using an electro-chemiluminescence immunoassay (Elecsys
Vitamin D total assay, Modular Analytics E170, Roche Diagnostics, Mannheim, Germany) (measuring
range 7.5–175.0 nmol/L, precision 0.1 nmol/L). Tests were performed according to the manufacturer’s
instructions [26].
Specific IgE levels were analyzed using ImmunoCAP fluoroenzyme immunoassay (Phadia 250,
Thermo Scientific, Uppsala, Sweden) (precision 0.01 kUA/L) for ImmunoCAP® allergen Fx5, a food
mix test detecting specific IgE to six major food allergens in children (cow’s milk, egg white, cod,
wheat, soybean and peanut). Tests were performed according to the manufacturer’s instructions and
classified as a positive test, using the term ‘IgE sensitized’, when specific IgE ≥ 0.35 kUA/L. In the case
of a positive test, specific IgE was further analyzed for each of the 6 major food allergens.
2.4. Other Variables
Background characteristics were chosen based on their availability in the original data and possible
associations with sensitization according to literature, e.g., season of birth [27], urban living [28],
firstborn child [29] and parental smoking during infancy [30,31]. Prior analyses of the data have shown
maternal education and maternal BMI to be the variables most associated with breastfeeding duration
and adherence to infant diet recommendations [32].
Information on parental variables including age, education, self-reported weight and height
(from which BMI was calculated) and smoking after birth, as well as information on the infant’s
siblings, was gathered from structured questionnaires answered by parents (usually the mother)
when the children were 12 months old. Parents’ education was defined as the highest level of
completed education categorized as basic education (finished elementary school) or longer based on
earlier publications [32]. Birth months were categorized as ‘winter/spring’ (November–April) and
‘summer/autumn’ (May–October) based on the expected contribution of sunlight exposure to maternal
vitamin D status around birth [13]. During follow-up at 6 years of age, parents answered another
questionnaire including questions on children’s regular use of antihistamines and asthma inhalers.
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The questionnaires were constructed for the primary outcomes of the study (dietary intake and growth)
and did not include questions about family history of atopy or maternal vitamin D supplementation
during pregnancy or lactation.
Information about weight, length and head circumference was gathered from maternity wards
(birth measurements) and primary healthcare facilities (as close to ages 2, 6 and 12 months as possible).
Weight was registered with 5 g precision, length measured on length boards and registered with 0.1 cm
precision and head circumference was registered with 0.1 cm precision. At follow-up, (mean age
73.4± 3.2 months) weight (Marel M series 110, Iceland) (precision 0.1 kg) and height (Ulmer stadiometer,
Professor Heinze, Busse design, Ulm, Germany) (precision 0.1 cm) were measured at Landspitali
University Hospital. Children were classified as being a normal weight or overweight/obese at 6 years
according to the World Health Organization’s (WHO) growth reference data for 5–19 years [33] and
the age-specific International Obesity Task Force (IOTF) cut-off points used in previous publications
from this cohort [34]. Gains in infant weight, length or head circumference were calculated for each
participant as the difference in measurements between two time points.
2.5. Statistical Analyses
Statistical analyses were performed with SAS (Enterprise Guide 4.3; SAS Institute Inc, Cary, NC,
USA). Variables were examined for normality using quantile-quantile plots. Categorical variables
were presented as n (%) and a chi-square used for comparison between groups. Normally distributed
continuous variables were presented as mean and standard deviations (SD) and compared using
two-sided t-tests. Non-normally distributed continuous variables were presented as medians and
25th to 75th percentiles and compared using the non-parametric Mann–Whitney U-test. Logistic
regression analyses were used to examine possible associations with sensitization at 6 years, adjusting
for maternal smoking during infancy, and presented as the odds ratio (OR) with its 95% confidence
intervals (CI). The level of significance was set at ≤0.05.
3. Results
Fourteen 6-year-old children (10%) were IgE sensitized, thereof eight to cow’s milk only; two to
cow’s milk and eggs; two to peanuts only; one to peanuts and eggs; and one to peanuts, wheat and soy.
Four IgE sensitized children and one non-sensitized child were reported as regular users of asthma
inhalers or antihistamine at 6 years. Table 1 presents the characteristics of the participants included
in this study. Two IgE sensitized children (15%) vs. four non-sensitized children (3%) had mothers
who reported smoking in the first year of the child’s life (p ≤ 0.05). Other background characteristics
did not differ significantly between the groups. Looking at infant growth, IgE sensitized children
gained significantly more weight and increased their head circumference significantly more in the
first 2 months of life than non-sensitized children. At 2–6 months and 6–12 months (data not shown),
no significant differences in weight gain or head circumference growth were observed. Depending on
the applied method, 16% of non-sensitized vs. 36% of IgE sensitized (WHO method, non-significant
(NS), p = 0.07) or 10% of non-sensitized vs. 29% of IgE sensitized (IOTF method, p = 0.04) were
classified as overweight/obese at 6 years.
Breastfeeding initiation rate was high (99%) and 88% of infants were still breastfed when introduced
to solid food. Neither exclusive breastfeeding, nor mixed breastmilk and infant formula or exclusively
infant formula, in the first year differed according to sensitization status. The average duration of
exclusive breastfeeding was 3.6 ± 1.9 months for non-sensitized children vs 2.9 ± 2.1 months for the IgE
sensitized (NS). The average duration of any breastfeeding was similar for non-sensitized vs sensitized
children. At 4 months 36% of IgE sensitized vs. 60% of non-sensitized children were exclusively
breastfed (NS, p = 0.08). However, as shown in Figure 1, a greater proportion of IgE sensitized than
non-sensitized children had been introduced to complementary solid food at or before 4 months of age
(17 weeks) (57% vs. 23%, respectively, p < 0.01). Introduction of solid foods prior to 4 months increased
the odds for sensitization, OR = 4.9 (95% CI = 1.4–16.6) when adjusted for maternal smoking.
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Table 1. Characteristics of the participants included in the study (n = 144).
Non-Sensitized n = 130 IgE Sensitized n = 14 p
Infant information
Boys, n (%) 65 (50) 9 (64) 0.31
Birth in winter/spring, n (%) 70 (54) 8 (57) 0.81
Urban living, n (%) 91 (70) 11 (79) 0.50
First born, n (%) 42 (36) 2 (17) 0.18
Exclusive breastfeeding, months 4 (2, 5) 4 (0, 4) 0.18
Any breastfeeding, months 8 (6, 10) 8 (7, 11) 0.97
Weight gain 0–2 months, kg 1.8 ± 0.5 2.2 ± 0.4 0.04
Weight gain 2–6 months, kg 2.4 ± 0.7 2.3 ± 0.7 0.59
Length gain 0–6 months 1, cm 16.8 ± 2.0 17.8 ± 1.7 0.09
Head circumference gain
0–2 months, cm 4.2 ± 1.0 4.9 ± 1.2 0.02
Head circumference gain
2–6 months, cm 4.2 ± 0.7 3.9 ± 0.8 0.15
Parent information 2
Maternal smoking, n (%) 4 (3) 2 (15) 0.05
Paternal smoking, n (%) 18 (16) 3 (23) 0.49
Maternal age, years 31.3 ± 4.8 33.2 ± 5.4 0.18
Paternal age, years 34.1 ± 5.7 36.5 ± 6.6 0.16
Maternal BMI, kg/m2 23.5 (21.4, 26.5) 26.6 (21.8, 33.2) 0.21
Paternal BMI, kg/m2 26.0 (24.3, 28.1) 26.6 (23.4, 28.7) 0.82
Basic education mother 3, n (%) 19 (16) 4 (31) 0.19
Basic education father 3, n (%) 26 (23) 4 (31) 0.52
Data presented as n (%), mean± SD or median (25th, 75th percentiles). Chi-square, two-sided t-test or Mann–Whitney
U-test used for comparison between groups. 1 Length gain 0–2 months and 2–6 months not reported due to a large
number of missing values for length at 2 months (missing n = 56). 2 From questionnaire answered when the infant
is 12 months old. 3 Elementary school (10 years in school) is the highest level of completed education.
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respectively, p = 0.03. This could partly be explained by less but non-significant vitamin D supplement 
use among IgE sensitized children (see Figure 2) and partly by less consumption of vitamin D fortified 
formula (consumed by 30% of IgE sensitized vs. 68% of non-sensitized children at 12 months, p = 
0.02). Higher vitamin D intake at 12 months was associated with a decreased odds for sensitization, 
OR = 0.8 (95%, CI = 0.7–0.996) when adjusted for maternal smoking. As shown in Figure 2, IgE 
sensitized children were less likely than non-sensitized children to use vitamin D supplements at 6 
years of age (23% vs. 56%, p = 0.03). Vitamin D supplement use at 6 years was associated with a 
decreased odds for sensitization, OR = 0.2 (95%, CI = 0.1–0.98), when adjusted for maternal smoking. 
The median intake of vitamin D at 6 years was 3.1 μg/d (2.1, 3.6) vs. 5.3 μg/d (2.3, 12.4) among IgE 
sensitized vs. non-sensitized children, respectively (NS, p = 0.09). Mean serum 25(OH)D did not differ 
between IgE sensitized and non-sensitized children, at either 12 months (96.8 ± 33.6 vs. 99.3 ± 32.2 
nmol/L, respectively) or 6 years (59.3 ± 15.9 vs. 56.0 ± 16.7 nmol/L, respectively). It should be noted 
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Total vitamin D intake at 12 months was lower among IgE sensitized than non-sensitized children,
presented as median (25th, 75th percentiles): 3.9 µg/d (3.2, 7.2) vs. 8.1 µg/d (4.4, 12.3), respectively,
p = 0.03. This could partly be explained by less but non-significant vitamin D supplement use among
IgE sensitized children (see Figure 2) and partly by less consumption of vitamin D fortified formula
(consumed by 30% of IgE sensitized vs. 68% of non-sensitized children at 12 months, p = 0.02). Higher
vitamin D intake at 12 months was associated with a decreased odds for sensitization, OR = 0.8 (95%,
CI = 0.7–0.996) when adjusted for maternal smoking. As shown in Figure 2, IgE sensitized children were
less likely than non-sensitized children to use vitamin D supplements at 6 years of age (23% vs. 56%,
p = 0.03). Vitamin D supplement use at 6 years was associated with a decreased odds for sensitization,
OR = 0.2 (95%, CI = 0.1–0.98), when adjusted for maternal smoking. The median intake of vitamin
D at 6 years was 3.1 µg/d (2.1, 3.6) vs. 5.3 µg/d (2.3, 12.4) among IgE sensitized vs. non-sensitized
children, respectively (NS, p = 0.09). Mean serum 25(OH)D did not differ between IgE sensitized and
non-sensitized children, at either 12 months (96.8 ± 33.6 vs. 99.3 ± 32.2 nmol/L, respectively) or 6 years
(59.3 ± 15.9 vs. 56.0 ± 16.7 nmol/L, respectively). It should be noted that only half of participants had
serum 25(OH)D measured at 12 months (69 non-sensitized and 7 IgE sensitized).
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that differed significantly according to sensitization), confirmed these results.  
The results add to the present literature about early life exposures on IgE outcomes in childhood, 
although this study is small and cannot determine causality. Also, a 9.7% IgE sensitization ratio at 6 
years is higher than found in other studies of Icelandic children, measured at a younger age [35–37]. 
Although we did not have clinical information on food allergies, increased serum levels of specific 
IgE detected by immunoassay are commonly associated with a higher likelihood of clinical atopic 
disease or food allergy [38–40] and the prevention of sensitization is considered important for the 
prevention of food allergies [2]. Therefore, our results of 57% of IgE sensitized vs. 23% of non-
sensitized children having been introduced to solid food at 4 months support the Nordic Nutrition 
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4. Discussion
In this population-based study of Icelandic children, solid food introduction prior to 4 months
was more common and total vitamin D intake at 12 months was lower among IgE sensitized vs.
non-sensitized children. Further ore, vitamin D supplement use at 6 years was less common among
IgE sensitized children. Logistic models adjusted for maternal smoking (the only background variable
that differed significantly according to sensitization), confirmed these results.
The results add to the present literature about early life exposures on IgE outcomes in childhood,
although this study is small and cannot determine causality. Also, a 9.7% IgE sensitization ratio at
6 years is higher than found in other studies of Icelandic children, measured at a younger age [35–37].
Although we did not have clinical information on food allergies, increased serum levels of specific IgE
detected by immunoassay are commonly associated with a higher likelihood of clinical atopic disease
or food allergy [38–40] and the prevention of sensitization is considered important for the prevention
of food allergies [2]. Therefore, our results of 57% of IgE sensitized vs. 23% of non-sensitized children
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having been introduced to solid food at 4 months support the Nordic Nutrition Recommendations
advice to delay complementary feeding until the infant is at least 4 months of age. They also seem to
support the current vitamin D supplementation recommendations in Iceland and the Nordic countries.
We did not observe significant differences in any or exclusive breastfeeding between IgE sensitized and
non-sensitized children, although there was a trend (p = 0.08) suggesting that IgE sensitized children
had lower rates of exclusive breastfeeding in infancy compared to non-sensitized children (36% vs.
60% at 4 months, respectively).
Literature suggests that by 4 months, the infant’s gut is sufficiently developed to receive and
digest solid food or any food beyond breastmilk and infant formula [41,42]. Associations between the
reduced relative abundance of potentially immunomodulatory gut bacteria and the development of
IgE-associated eczema have also been suggested [43]. While some studies [44–47] but not all [48,49]
propose that introduction of allergenic solid food from 3–4 months of age is safe and may lead to
tolerance and protection against IgE-mediated food allergy, associations between solid food introduction
prior to 4 months, faster infant growth and childhood obesity have been reported [50–54]. Our findings
indicate interesting differences between the IgE sensitized and non-sensitized children in growth rate
in infancy and perhaps also in the prevalence of body weight above the normal reference value at
6 years. Infant feeding (breastfeeding or early introduction of solid foods) may be a confounder in
this, e.g., through higher infant energy and/or protein intake. Faster weight gain in infancy has been
associated with an increased risk of allergic rhinitis [55], asthma [56–59], impaired lung function [60–62]
and wheezing [55,63]. To the best of our knowledge, other studies have not observed the trend we
see on less gain in postnatal head circumference among IgE sensitized children compared to their
non-sensitized peers. It has been hypothesized that childhood obesity may promote immunological
changes increasing the risk for allergy [64] but the evidence remains uncertain [65]. Previous papers
from the currently studied population-based Icelandic cohort born in the year 2005, with extensive and
detailed information on both dietary intake and growth throughout the first year of life and follow-up
at 6 years of age, have shown associations between infant nutrition and growth up to 6 years. Solid food
prior to 6 months of age and high protein intake and especially animal protein intake at 9–12 months
has been associated with a body mass index above the normal range at the age of 6 years [23,66,67].
A Cochrane review from 2016 found no evidence to disagree with recommendations for healthy
infants of exclusive breastfeeding for the first 6 months [68]. A more recent systematic review found
moderate evidence suggesting that a short breastfeeding duration, or no breastfeeding, was associated
with a higher risk of childhood asthma [11]. The same review found limited evidence for the effect of
either a short breastfeeding duration or no breastfeeding on food allergies, allergic rhinitis and atopic
dermatitis [11]. Another systematic literature review found limited to strong evidence, depending on
the food in question, to suggest that introducing allergenic foods after 4 months of age does not affect
the risk of food allergy and atopic dermatitis/eczema but may decrease the risk of later peanut and egg
allergies [12]. Findings summarized in these reviews, and other papers, have resulted in changes to the
older dietary advice about avoiding allergenic foods during the first year of life. Further studies are
needed with a focus on diet in infancy and atopic disease, but our results on solid food introduction
harmonize with these recent systematic reviews.
Vitamin D intake is important for all infants as well as children and adults with little sun exposure
in all Nordic countries. Official recommendations in Iceland put special emphasis on vitamin D intake
from the diet and supplements due to the country’s geographical location at 63–66◦ N, resulting in
limited endogenous vitamin D synthesis for many months of the year [69,70]. It has been hypothesized
that the relationship between vitamin D status and allergy may not be linear and that both low and high
vitamin D status may be associated with elevated IgE levels [71]. While childhood vitamin D deficiency
has been associated with increased asthma risk [72] and higher levels of IgE sensitization [15,16],
other studies, from Finland, Sweden and Australia suggest that infant vitamin D supplementation
may increase the risk for atopy and allergy later in life [17–19]. In the Northern Finland Birth Cohort
1966, the majority of infants used vitamin D supplements in doses of 50 µg/d [17], which is considered
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the upper limit for children, and too high in the first year of life [3]. In our cohort, no 12-month-old
infant was considered vitamin D deficient (25-hydroxyvitamin D < 30 nmol/L) and vitamin D intake
from diet and supplements combined did not exceed 25 µg/d in infancy or at 6 years [13,14]. A recent
Icelandic study reported associations between postnatal cod liver oil consumption and decreased food
sensitization and clinical food allergy in infants [35]. The present study found lower total vitamin D
intake at 12 months and lower vitamin D supplement use (mainly cod liver oil) at 6 years among IgE
sensitized children compared to non-sensitized. Previous work on this data has shown correlations
between vitamin D supplement use in late infancy and at 6 years [73]. It is possible that children using
vitamin D supplements at 6 years have been more likely than others to use vitamin D supplements
from 1–6 years of age and it may therefore be viewed as a proxy for vitamin D supplement use in
early childhood. We did not see a difference in vitamin D status by sensitization, but the small sample
size may have weighted very heavily there, especially if the relationship between vitamin D and
sensitization may not be linear [71]. We did not have information about maternal vitamin D intake
during pregnancy or lactation.
Cod liver oil is a good source of both vitamin D and n-3 PUFA. Vitamin D modulates the action of
immune cells, such as T and B cells, monocytes and dendritic cells, in an interplay between the innate
and adaptive immune systems [74]. We cannot exclude an effect from the intake of n-3 PUFA on IgE
sensitization in the current study [75].
The strength of our study lies in the detailed longitudinal data on infant feeding, vitamin D
supplement use and growth from birth to 6 years in a population-based sample, which makes it an
important contribution to the literature. The thorough and direct methods of data collection decrease
unexplained variabilities and increase the validity of the data. For the investigated population at
northern latitudes the results on vitamin D intake are important.
We acknowledge that our study is limited by the number of participants, resulting, for example,
in wide confidence intervals, and results should therefore be cautiously interpreted, but the cohort’s size
was sufficiently large for the findings we observe. There is no reason to think the sample selection process
influenced the results or affected feeding practices or vitamin D supplementation. Also, the representativeness
of the sample is good. Therefore the significant effects or associations observed do firmly exist, although
other associations cannot be excluded. The inclusion criteria; born at term, Icelandic (Caucasian) parents
and absence of disease, must however be kept in mind when interpreting the results and may limit the
generalizability of the findings.
5. Conclusions
The results support the NNR on not introducing complementary solid food before the age of
4 months and encouraging vitamin D intake from diet and supplements for Nordic infants and children.
The results also indicated interesting differences between the IgE sensitized and non-sensitized children
in growth rate in infancy and perhaps also in prevalence of body weight above the normal reference
value at 6 years, which warrant further studies. Although not significant, we observed lower rates of
exclusive breastfeeding in infancy for IgE sensitized children compared with non-sensitized children,
which could be investigated in a larger sample.
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